The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients

被引：0
|
作者：
P Dubsky
J C Brase
R Jakesz
M Rudas
C F Singer
R Greil
O Dietze
I Luisser
E Klug
R Sedivy
M Bachner
D Mayr
M Schmidt
M C Gehrmann
C Petry
K E Weber
K Fisch
R Kronenwett
M Gnant
M Filipits
机构：
[1] Medical University Vienna,Department of Surgery and Comprehensive Cancer Center
[2] Sividon Diagnostics,Department of Pathology
[3] Medical University Vienna,Department of Obstetrics and Gynecology
[4] Medical University Vienna,Medical Department
[5] Paracelsus University of Salzburg,Department of Pathology
[6] Paracelsus University of Salzburg,Department of Surgery
[7] Hospital Guessing,Department of Pathology
[8] Hospital of Oberwart,Department of Pathology
[9] Hospital of St. Poelten,Department of Surgery
[10] Hospital of St. Poelten,Department of Internal Medicine 3
[11] General Hospital of Linz,Department of Gynecology and Obstetrics
[12] University of Mainz,Department of Cancer Research and Comprehensive Cancer Center
[13] Bayer Technology Services GmbH,undefined
[14] Medical University Vienna,undefined
来源：
British Journal of Cancer | 2013年 / 109卷
关键词：
EndoPredict; endocrine therapy; late relapse;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2959 / 2964
页数：5
相关论文
共 50 条
  • [1] The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2-breast cancer patients
    Dubsky, P.
    Brase, J. C.
    Jakesz, R.
    Rudas, M.
    Singer, C. F.
    Greil, R.
    Dietze, O.
    Luisser, I.
    Klug, E.
    Sedivy, R.
    Bachner, M.
    Mayr, D.
    Schmidt, M.
    Gehrmann, M. C.
    Petry, C.
    Weber, K. E.
    Fisch, K.
    Kronenwett, R.
    Gnant, M.
    Filipits, M.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 109 (12) : 2959 - 2964
  • [2] The EndoPredict score identifies late distant metastases in ER+/HER2-breast cancer patients
    Dubsky, P.
    Brase, J. C.
    Fisch, K.
    Jakesz, R.
    Singer, C. F.
    Greil, R.
    Dietze, O.
    Weber, K. E.
    Petry, C.
    Kronenwett, R.
    Rudas, M.
    Knauer, M.
    Gnant, M.
    Filipits, M.
    [J]. CANCER RESEARCH, 2012, 72
  • [3] Decentral gene expression analysis for ER+/Her2− breast cancer: results of a proficiency testing program for the EndoPredict assay
    Carsten Denkert
    Ralf Kronenwett
    Werner Schlake
    Kerstin Bohmann
    Roland Penzel
    Karsten E. Weber
    Heinz Höfler
    Ulrich Lehmann
    Peter Schirmacher
    Katja Specht
    Margaretha Rudas
    Hans-Heinrich Kreipe
    Peter Schraml
    Gudrun Schlake
    Zsuzsanna Bago-Horvath
    Frank Tiecke
    Zsuzsanna Varga
    Holger Moch
    Marcus Schmidt
    Judith Prinzler
    Dontscho Kerjaschki
    Bruno Valentin Sinn
    Berit Maria Müller
    Martin Filipits
    Christoph Petry
    Manfred Dietel
    [J]. Virchows Archiv, 2012, 460 : 251 - 259
  • [4] The Added Prognostic Value of Oncotype Recurrence Score to AJCC Prognostic Staging System in Stage III ER+/HER2− Breast Cancer
    Maoli Wang
    Mingdi Zhang
    Hongliang Chen
    [J]. Advances in Therapy, 2023, 40 : 3912 - 3925
  • [5] Prognostic performance of the EndoPredict score in node-positive chemotherapy-treated ER+/HER2-breast cancer patients: results from the GEICAM/9906 trial.
    Martin, M.
    Brase, J. C.
    Ruiz-Borrego, M.
    Krappmann, K.
    Munarriz, B.
    Fisch, K.
    Ruiz, A.
    Weber, K. E.
    Crespo, C.
    Petry, C.
    Rodriguez, C. A.
    Kronenwett, R.
    Calvo, L.
    Alba, E.
    Carrasco, E.
    Casas, M.
    Caballero, R.
    Rodriguez-Lescure, A.
    [J]. CANCER RESEARCH, 2012, 72
  • [6] HER2−/ER+-Brustkrebs: fehlende Taxoleffektivität?HER2−/ER+ breast cancer: lack of effectiveness of taxol?
    N. Bangemann
    [J]. Der Onkologe, 2008, 14 (2): : 198 - 200
  • [7] Prognostic Value of HER2 Status in Breast Cancer Patients With Brain Metastases
    Tsuruoka, S.
    Kataoka, M.
    Uwatsu, K.
    Nishikawa, A.
    Mochizuki, T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E51 - E51
  • [8] Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer
    C. Criscitiello
    A. Vingiani
    P. Maisonneuve
    G. Viale
    G. Viale
    G. Curigliano
    [J]. Breast Cancer Research and Treatment, 2020, 183 : 347 - 354
  • [9] Prognostic value of neutrophil-lymphocyte ratio in early breast cancer patients with ER+/Her2 negative and its association with 21 gen recurrence score
    Maldonado-Noboa, Ivan
    Cabrera-Galeana, Paula
    Arce-Salinas, Claudia
    Elena Lara, Maria
    Cuamani-Mitznahuatl, Gerardo
    Ladron De Guevara, Diego
    Ordonez, Adan
    Bargallo-Rocha, Enrique
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [10] Comparison of risk classification between EndoPredict and Mammaprint scores in ER+/HER2-invasive breast cancer
    Garcia, A. Pelaez
    Yebenes, L.
    Angulo, A.
    Befion, A.
    Zamora, P.
    Mendez, J. I. Sanchez
    Espinosa, E.
    Redondo, A.
    Mendiola, M.
    Hardisson, D.
    [J]. VIRCHOWS ARCHIV, 2016, 469 : S22 - S22
12345